TNFRSF1B and acute myeloid leukemia: investigated the functions of TNF-related apoptosis-inducing ligand (TRAIL) receptors and found that when TNFRSF1B expression was inhibited, a less differentiated phenotype of acute myeloid leukemia (AML) cells conferred resistance to NK cell cytotoxicity.